Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Total virus titer in minutes

Abstract: In this Application Note, we review how using nanoparticle tracking analysis, have been employed for the direct visualization, concentration measurement and sizing of bacteriophages and viruses

Introduction

The titer of bacteriophage and virus particles is established by plaque assay or, in the case of animal cell viruses, by a cell-based bioassay. In these array systems, infective virus particles are grown in confluent cell layers to produce plaques (zones of destroyed cells) which can be counted to determine the number of plaque forming units (pfu). While this gives a direct count of individual infective virus particles, non-infective virus particles do not produce plaques, and aggregates containing many virus particles will produce only single plaques. Often, the manufacturer needs to know the number of virus particles in the preparation, whether infective or not, and the degree, if any, to which the preparation is undergoing aggregation as an early indicator of limited shelf life.

Nanoparticle Tracking Analysis (NTA) allows nanoscale particles such as viruses and virus aggregates to be directly and individually visualized in liquids in real-time, from which high resolution particle size distribution profiles can be obtained. The technique is fast, robust, accurate and low cost, representing an attractive complement to existing methods of nanoparticle analysis such as Dynamic Light Scattering (DLS), Photon Correlation Spectroscopy (PCS) or Electron Microscopy (EM).

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Related White Papers

Integrated workflow for rapid selection and optimization of hybridoma cell lines

| Contributed by ForteBio

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

A Fast and High Precision Influenza Vaccine Potency Assay

| Contributed by ForteBio

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register